28 results
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
29 Apr 24
Enlivex CEO Issues Letter to Shareholders – Perspectives on Recent Events
8:01am
of osteoarthritis is enormous, and the need for treatments that reduce pain and attendant disability for persons with osteoarthritis is critical
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
22 Apr 24
Report of Foreign Private Issuer
8:02am
replacement. The burden of osteoarthritis is enormous, and the need for treatments that reduce pain and attendant disability for persons with osteoarthritis
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
16 Apr 24
Report of Foreign Private Issuer
8:00am
, primarily for total joint replacement. The burden of osteoarthritis is enormous, and the need for treatments that reduce pain and attendant disability
6-K
EX-99.1
3eq1vu2jajimtrcsrz
19 May 20
Annual and Extraordinary General Meeting of Shareholders
8:04am
20-F/A
vn8yfa6fdylg atfwl
23 Jan 20
Annual report (foreign) (amended)
4:31pm
6-K
EX-99.2
qlx 1ukc7wfck8
6 Dec 18
Amended Notice of Annual and Extraordinary General Meeting of the Shareholders
4:43pm
6-K
EX-99.1
ebbkcbe654 yro
19 Nov 18
Agreement and Plan of Merger
4:34pm